Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xylo Technologies Ltd. Sponsored Adr (XYLO)
:XYLO
Holding XYLO?
Track your performance easily
XYLO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.70 - $9.18
Previous CloseN/A
Volume11.59K
Average Volume (3M)14.55K
Market Cap
$3.24M
Enterprise Value$2.66M
Total Cash (Recent Filing)$6.33M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.51
Next Earnings
Apr 30, 2025EPS EstimateN/A
Last Dividend Ex-Date
Dec 19, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-23.59
Shares Outstanding747,332
10 Day Avg. Volume16,056
30 Day Avg. Volume14,549
Standard Deviation0.25
R-Squared0.09
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.04
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.82
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.18
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Xylo Technologies Ltd News
PremiumCompany Announcements
Xylo Technologies Faces Privatization Proposal by Major Shareholder
PremiumCompany Announcements
Xylo Technologies Offers Pre-Funded Warrant for ADSs
PremiumCompany Announcements
Xylo Technologies Gains Shareholder Approval at AGM
PremiumCompany Announcements
Xylo Technologies Announces Upcoming Shareholder Meeting
PremiumCompany Announcements
Xylo Technologies Reports Decreased Assets and LiabilitiesPremiumCompany Announcements
Xylo’s ParaZero Boosts Medical Delivery with Drone Safety Tech
PremiumCompany Announcements
Xylo Technologies Unveils Sustainable Urban Cargo BikeOwnership Overview
―
Insiders
0.03%
Mutual Funds
<0.01% Other Institutional Investors
99.97% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
XYLO FAQ
What was Xylo Technologies Ltd. Sponsored Adr’s price range in the past 12 months?
Xylo Technologies Ltd. Sponsored Adr lowest stock price was $2.70 and its highest was $9.18 in the past 12 months.
What is Xylo Technologies Ltd. Sponsored Adr’s market cap?
Xylo Technologies Ltd. Sponsored Adr’s market cap is $3.24M.
When is Xylo Technologies Ltd. Sponsored Adr’s upcoming earnings report date?
Xylo Technologies Ltd. Sponsored Adr’s upcoming earnings report date is Apr 30, 2025 which is in 99 days.
How were Xylo Technologies Ltd. Sponsored Adr’s earnings last quarter?
Xylo Technologies Ltd. Sponsored Adr released its earnings results on Sep 02, 2024. The company reported -$6.32 earnings per share for the quarter, the consensus estimate of -$6.32 by $0.
Is Xylo Technologies Ltd. Sponsored Adr overvalued?
According to Wall Street analysts Xylo Technologies Ltd. Sponsored Adr’s price is currently Overvalued.
Does Xylo Technologies Ltd. Sponsored Adr pay dividends?
Xylo Technologies Ltd. Sponsored Adr pays a Notavailable dividend of $2.16 which represents an annual dividend yield of N/A. See more information on Xylo Technologies Ltd. Sponsored Adr dividends here
What is Xylo Technologies Ltd. Sponsored Adr’s EPS estimate?
Xylo Technologies Ltd. Sponsored Adr’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Xylo Technologies Ltd. Sponsored Adr have?
Xylo Technologies Ltd. Sponsored Adr has 747,332 shares outstanding.
What happened to Xylo Technologies Ltd. Sponsored Adr’s price movement after its last earnings report?
Xylo Technologies Ltd. Sponsored Adr reported an EPS of -$6.32 in its last earnings report, expectations of -$6.32. Following the earnings report the stock price went up 2.546%.
Which hedge fund is a major shareholder of Xylo Technologies Ltd. Sponsored Adr?
Currently, no hedge funds are holding shares in XYLO
---
Company Description
Xylo Technologies Ltd. Sponsored Adr
Medigus Ltd. is a medical device company, which engages in the research and development, manufacture, and sale of endosurgical tools and instruments. It specializes in the area of Gastroesophageal reflux disease. Its product MUSE System offers minimal invasive endoscopic devices and procedures for gastric surgery. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Omer, Israel.
---
Technical Analysis
Aethlon Medical
―
EKSO BIONICS
―
Inovio Pharmaceuticals
―
Precipio
―
Viveve Medical
―
vTv Therapeutics
―
---